About LEAPFROG BIO, INC.
Leapfrog Bio is a biotechnology company focused on accelerating precision oncology by targeting genetic vulnerabilities in cancers driven by loss-of-function mutations using its proprietary OncoSLX platform. The company aims to develop precision therapeutics by repurposing de-risked clinical-stage drugs.
Discovery and targeting of genetic vulnerabilities in cancersDevelopment of precision therapeutics using de-risked clinical-stage drugsUtilization of the OncoSLX platform for pharmacologically based synthetic lethality screeningIdentification of actionable vulnerabilities in loss-of-function mutation-driven cancers
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to LEAPFROG BIO, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.